Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Virtus LifeSci Biotech Clinical Trials ETF
BBC performance and flow charts
Performance
Flows
Historic performance and flows
Data as of September 11, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -5.78% | +17.22% | +27.77% | +102.82% | +137.50% | +6.45% |
| Flows | - | +$83K | +$5M | +$12M | +$16M | +$8M |
Characteristics
The Virtus LifeSci Biotech Clinical Trials ETF is built to track the LifeSci Biotechnology Clinical Trials Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | VIRTUS Investment Partners |
| N° of holdings | 127 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | December 16, 2014 |
| ESG | No |
More data and info about BBC on Trackinsight
Exposure
Data as of July 31, 2026Diversification
Total weight of top 15 holdings out of 127
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +33.39% | +36.22% | +37.22% | +39.64% |
Max drawdown | -11.65% | -14.64% | -54.25% | -70.43% |
Max drawdown duration | 23d | 60d | 340d | 1666d |
Time to recover | N/A | 10d | 193d | 374d |
Replication quality
Data as of August 31, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is BBC?
BBC is a Passive ETF that provides exposure to Equity assets. It is managed by VIRTUS Investment Partners.
What index does BBC track?
BBC tracks the LifeSci Biotechnology Clinical Trials Total Return Index - USD, aiming to replicate its performance through full replication.
What does BBC invest in?
This ETF provides exposure to Equally Weighted US Equities. It is part of the segment: Tomorrow's Treatments.
What is the expense ratio of BBC?
The total expense ratio (TER) of BBC is 0.65%, representing the annual fee charged by the fund manager.
When was BBC launched?
BBC was launched on December 16, 2014, marking its entry into the ETF market.
Who is the issuer of BBC?
BBC is issued by VIRTUS Investment Partners.
What is the AUM of BBC?
As of September 11, 2026, BBC manages $46.95 M, reflecting the total assets held in the fund.
How has BBC performed recently?
As of September 11, 2026, BBC delivered a return of -5.78% over the past month (1M performance), 17.22% over the past three months (3M), and 27.77% year-to-date (YTD).
Does BBC pay dividends?
As of September 11, 2026, BBC has a trailing 12-month distribution yield of 1.33%.
How many holdings are in BBC
As of July 31, 2026, BBC holds 127 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is BBC?
As of July 31, 2026, BBC holds 127 securities, with 15.32% of its assets concentrated in its top 15 holdings.
What are the top holdings of BBC?
As of July 31, 2026, BBC holds a portfolio of 127 underlyings, with its largest positions including First Tracks Biotherapeutics, Inc., Monopar Therapeutics, Inc. and MBX Biosciences, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does BBC invest in?
As of July 31, 2026, BBC has its largest geographic exposures in USA.
What sectors or themes does BBC focus on?
As of July 31, 2026, BBC is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
ETF Trends
ETF Industry KPIs September 8, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs August 31, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs August 24, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
What’sTheFund
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)
James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.
Browse all educational columns
Expert-Built ETF Portfolios, All in One Place
Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.
